NYXOAH SA - ORDINARY SHARES

Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

14 Sep 2021 02:00:00 By Nasdaq GlobeNewswire

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference

13 Sep 2021 16:30:00 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

12 Sep 2021 16:30:00 By Nasdaq GlobeNewswire

Nyxoah Announces Participation in the Baird 2021 Global Healthcare Conference

02 Sep 2021 16:30:00 By Nasdaq GlobeNewswire

Publication relating to transparency notifications

01 Sep 2021 16:30:00 By Nasdaq GlobeNewswire

Nyxoah Issues First Half 2021 Financial Results

31 Aug 2021 16:30:00 By Nasdaq GlobeNewswire

Nyxoah Appoints Rita Johnson-Mills to its Board of Directors

27 Aug 2021 16:30:00 By Nasdaq GlobeNewswire

Nyxoah to Release First Half 2021 Financial Results on August 31 and Host Earnings Conference Call on September 1, 2021

11 Aug 2021 16:30:00 By Nasdaq GlobeNewswire

Publication relating to a transparency notification

19 Jul 2021 16:30:00 By Nasdaq GlobeNewswire

Publication relating to a transparency notification

14 Jul 2021 16:30:00 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

09 Jul 2021 16:30:00 By Nasdaq GlobeNewswire

Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters’ Full Exercise of Option to Purchase Additional Shares

08 Jul 2021 16:30:00 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

07 Jul 2021 16:30:00 By Nasdaq GlobeNewswire

Nyxoah Announces Pricing of Nasdaq Public Offering

02 Jul 2021 08:40:27 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

29 Jun 2021 13:00:00 By Nasdaq GlobeNewswire

Nyxoah Announces Launch of Proposed Public Offering in the United States

25 Jun 2021 06:30:00 By Nasdaq GlobeNewswire

Nyxoah Issues First Quarter 2021 Results

10 Jun 2021 17:46:43 By Nasdaq GlobeNewswire

Nyxoah files Registration Statement for Proposed Initial Public Offering in the United States

10 Jun 2021 17:41:43 By Nasdaq GlobeNewswire

Nyxoah BETTER SLEEP Trial Reaches its Primary Endpoints

07 Jun 2021 01:00:00 By Nasdaq GlobeNewswire

Publication relating to a transparency notification

26 May 2021 13:25:33 By Nasdaq GlobeNewswire